The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday endorsed Novavax’s more conventional COVID-19 vaccine for use as a primary shot for eligible Americans aged 18 and older.
The CDC’s independent advisory committee voted unanimously to recommend the vaccine for adults after reviewing safety and effectiveness data at a public meeting on Tuesday.